STCube, Inc. Stock

Equities

A052020

KR7052020005

Electronic Equipment & Parts

End-of-day quote Korea S.E. 06:00:00 2024-04-25 pm EDT 5-day change 1st Jan Change
5,190 KRW +2.98% Intraday chart for STCube, Inc. +10.66% -56.31%
Sales 2022 6.3B 4.58M Sales 2023 5.83B 4.23M Capitalization 553B 401M
Net income 2022 -18.89B -13.72M Net income 2023 -24.5B -17.79M EV / Sales 2022 93.7 x
Net cash position 2022 49.94B 36.26M Net cash position 2023 33B 23.96M EV / Sales 2023 89.2 x
P/E ratio 2022
-30.4 x
P/E ratio 2023
-22.5 x
Employees 13
Yield 2022 *
-
Yield 2023
-
Free-Float 94.97%
More Fundamentals * Assessed data
Dynamic Chart
STCube, Inc.(KOSDAQ:A052020) dropped from S&P Global BMI Index CI
Global markets live: Apple, Alphabet, Roku, Amazon, General Mills... Our Logo
STCube, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022 CI
STCube to Raise $36 Million via Stock Sale; Shares Surge 10% MT
STCube, Inc. announced that it has received KRW 9.9999921 billion in funding from Newgreen Co. Ltd. and another investor CI
STCube, Inc. announced that it expects to receive KRW 9.9999921 billion in funding from Newgreen Co. Ltd. and another investor CI
Samsung Biologics Signs Additional Development and Manufacturing Agreement with STCube CI
Samsung Biologics and STCube Enter into Development and Manufacturing Agreement for Novel Target Anticancer Drug CI
STCube, Inc. announced that it has received KRW 41.999908468 billion in funding from Mirae Asset Daewoo Co., Ltd., Investment Arm, Shinhan Investment Corp., Samsung Securities Co.,Ltd., Hana Bank, Investment Arm CI
STCube, Inc. announced that it expects to receive KRW 41.999908468 billion in funding from Mirae Asset Daewoo Co., Ltd., Investment Arm, Shinhan Investment Corp., Samsung Securities Co.,Ltd., Hana Bank, Investment Arm and other investors CI
STCube, Inc.(KOSDAQ:A052020) added to S&P Global BMI Index CI
STCube, Inc. announced that it has received KRW 5 billion in funding from Hanyang Securities Co. Ltd., Investment Arm. CI
STCube, Inc. announced that it expects to receive KRW 5 billion in funding from Hanyang Securities Co. Ltd., Investment Arm. CI
STCube, Inc. cancelled the acquisition of Bio Medical Holdings Co., Ltd. CI
Animation International Holdings, Limited acquired an additional 5.86% stake in STCube, Inc.. CI
More news
1 day+2.98%
1 week+10.66%
Current month-6.65%
1 month-16.29%
3 months-40.14%
6 months-51.22%
Current year-56.31%
More quotes
1 week
4 430.00
Extreme 4430
5 540.00
1 month
4 350.00
Extreme 4350
7 020.00
Current year
4 350.00
Extreme 4350
12 700.00
1 year
4 350.00
Extreme 4350
21 050.00
3 years
4 350.00
Extreme 4350
28 500.00
5 years
4 350.00
Extreme 4350
28 500.00
10 years
1 855.00
Extreme 1855
28 600.00
More quotes
Managers TitleAgeSince
Chief Executive Officer 59 13-02-28
Director of Finance/CFO 51 13-02-28
Director/Board Member 56 16-02-29
Members of the board TitleAgeSince
Chief Executive Officer 59 13-02-28
Director of Finance/CFO 51 13-02-28
Director/Board Member 59 14-02-28
More insiders
Date Price Change Volume
24-04-25 5,190 +2.98% 167 240
24-04-25 5,040 -4.36% 259,980
24-04-24 5,270 +16.21% 515,740
24-04-23 4,535 -6.49% 252,607
24-04-22 4,850 -3.96% 173,985

End-of-day quote Korea S.E., April 25, 2024

More quotes
STCube, Inc. is a Korea-based company mainly engaged in the distribution of lenses and related components. Along with subsidiaries, the Company operates its business through two segments. The Information Technology (IT) segment is engaged in the distribution of closed-circuit television (CCTV) lenses and related components. The Biotechnology (BT) segment is engaged in the development and licensing of immunomodulatory anticancer drug therapeutic candidates.
More about the company
  1. Stock Market
  2. Equities
  3. A052020 Stock